Preclinical models are research tools used to test new treatments before trying them ... single behaviour is guaranteed to prevent dementia - but there's lots of evidence to suggest that making ...

A groundbreaking discovery by scientists at Japan’s RIKEN Center for Brain Science has revealed an unexpected link between dopamine and Alzheimer’s disease. This revelation could mark a major ...

There's still so much we don't know about Alzheimer's disease, but the link between poor sleep and worsening disease is one ...

Kathy Ingebrand was diagnosed with Alzheimer's at 59 years old. "This patient is receiving a treatment ... her insurance will cover the cost. There are possible side effects, Bazakos said ...

China's medical regulator has approved Eli Lilly's treatment for early Alzheimer's, providing patients with another option after Eisai and Biogen's Leqembi received approval in January ...

Vitamin D also helps clear beta amyloid, a protein that plays a role in Alzheimer’s disease, Merrill points out. This is “the ...

The small miracles that 2024 brought to our lives lay the groundwork for new revolutionary treatments that are being prepared ...

(“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease ...

Former study was recently accepted in a peer-reviewed medical journal with focus on Alzheimer’s disease titled, “Blarcamesine for the treatment ... efficacy or safety. There is no guarantee ...

when it had rejected the treatment by saying the risk of serious brain swelling did not outweigh its small impact on slowing cognitive decline. Alzheimer's is the most common cause of dementia and ...

(This Dec. 17 story has been corrected to say that the EU regulator reversed its July decision in November to recommend approval for Biogen's drug, Leqembi, in paragraph 8) (Reuters) - China's medical ...